David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Tucows
TCX
$104M
| $564K | ﹤0.01% |
9,305
+66
| +0.7% | +$4.1K |
|
3002
OrthoPediatrics
KIDS
$655M
| $563K | ﹤0.01% |
21,140
+5,159
| +32% | +$110K |
|
3003
Microvision
MVIS
$52M
| $563K | ﹤0.01% |
+33,501
| New | +$666K |
|
3004
CALL
Ameriprise Financial
AMP
$49.6B
| $560K | ﹤0.01% |
+4,000
| New | +$567K |
|
|
REGI
3005
DELISTED
Renewable Energy Group, Inc.
REGI
| $560K | ﹤0.01% |
31,388
-243,528
| -89% | -$3.77M |
|
3006
CALL
GoDaddy
GDDY
$12.7B
| $558K | ﹤0.01% |
+7,900
| New | +$537K |
|
|
CERN
3007
DELISTED
Cerner Corp
CERN
| $558K | ﹤0.01% |
9,337
-352,245
| -97% | -$20.8M |
|
3008
Camden National
CAC
$961M
| $557K | ﹤0.01% |
12,184
+3,576
| +42% | +$162K |
|
|
SKX
3009
DELISTED
Skechers
SKX
| $556K | ﹤0.01% |
18,527
-135,312
| -88% | -$4.33M |
|
3010
PUT
Williams Companies
WMB
$86.8B
| $556K | ﹤0.01% |
+20,500
| New | +$541K |
|
3011
PUT
World Acceptance Corp
WRLD
$887M
| $555K | ﹤0.01% |
+5,000
| New | +$546K |
|
|
GOOD
3012
Gladstone Commercial Corp
GOOD
$638M
| $554K | ﹤0.01% |
+28,806
| New | +$524K |
|
3013
CALL
Canadian Solar
CSIQ
$972M
| $551K | ﹤0.01% |
+45,000
| New | +$676K |
|
3014
CALL
Nice
NICE
$5.87B
| $550K | ﹤0.01% |
+5,300
| New | +$537K |
|
3015
Artivion
AORT
$1.31B
| $549K | ﹤0.01% |
19,696
-12,463
| -39% | -$314K |
|
3016
Marriott Vacations Worldwide
VAC
$3.93B
| $549K | ﹤0.01% |
4,862
-8,316
| -63% | -$1.03M |
|
|
XLRN
3017
DELISTED
Acceleron Pharma
XLRN
| $547K | ﹤0.01% |
+11,282
| New | +$411K |
|
|
LTS
3018
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $547K | ﹤0.01% |
160,974
+24,697
| +18% | +$86.5K |
|
3019
CALL
Rogers Corp
ROG
$2.19B
| $546K | ﹤0.01% |
4,900
-6,000
| -55% | -$701K |
|
3020
PUT
International Flavors & Fragrances
IFF
$21.9B
| $545K | ﹤0.01% |
+4,400
| New | +$575K |
|
3021
Exponent
EXPO
$3.37B
| $544K | ﹤0.01% |
11,257
-37,679
| -77% | -$1.73M |
|
|
DBD
3022
DELISTED
Diebold Nixdorf Incorporated
DBD
| $544K | ﹤0.01% |
45,510
-408,569
| -90% | -$5.47M |
|
3023
MakeMyTrip
MMYT
$5.67B
| $543K | ﹤0.01% |
15,009
+5,014
| +50% | +$180K |
|
3024
CALL
Cullen/Frost Bankers
CFR
$10.2B
| $541K | ﹤0.01% |
5,000
+2,500
| +100% | +$282K |
|
3025
Ingevity
NGVT
$2.37B
| $541K | ﹤0.01% |
+6,695
| New | +$532K |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.